Cargando…
The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer
BACKGROUND: To identify the prevalence and clinical outcomes of pT0 disease following neoadjuvant hormonal therapy (NHT) and radical prostatectomy (RP) in high-risk prostate cancer. METHODS: We retrospectively included 111 patients who had received NHT and RP for the treatment of high-risk prostate...
Autores principales: | Joung, Jae Young, Kim, Jeong Eun, Kim, Sung Han, Seo, Ho Kyung, Chung, Jinsoo, Park, Weon Seo, Hong, Eun Kyung, Lee, Kang Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535612/ https://www.ncbi.nlm.nih.gov/pubmed/26269129 http://dx.doi.org/10.1186/s12894-015-0079-5 |
Ejemplares similares
-
Prostate Volume has Prognostic Value Only in Pathologic T2 Radical Prostatectomy Specimens
por: Cho, In-Chang, et al.
Publicado: (2011) -
Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy
por: Kim, Sung Han, et al.
Publicado: (2016) -
Prostate stem cell antigen mRNA in blood is a predictor of survival after radical prostatectomy in patients with high-risk prostate cancer
por: Suh, Yoon Seok, et al.
Publicado: (2018) -
Effect of Neoadjuvant Hormone Therapy on Resection Margin and Survival Prognoses in Locally Advanced Prostate Cancer after Prostatectomy Using Propensity-Score Matching
por: Kim, Sung Han, et al.
Publicado: (2018) -
Prostate Specific Membrane Antigen mRNA in Blood as a Potential Predictor of Biochemical Recurrence after Radical Prostatectomy
por: Joung, Jae Young, et al.
Publicado: (2010)